Dr. Jude Fitzgibbon, Barts Cancer Institute - Part 2: Understanding the Molecular Evolution of AML
 28 May 2013

In this video Dr. Jude Fitzgibbon, Barts Cancer Institute, Queen Mary University of London discusses his work investigating the molecular evolution of familial Acute Myeloid Leukemia (AML). He explains how his laboratory has investigated clinical heterogeneity between families involving at least three inherited gene mutations that can result in familial leukemia. Jude tells SelectScience how this work has implications for the clinical management of these families and how exome sequencing will enable more personalized treatment of familial AML by identifying additional co-operating mutations.

1 of 83 Page 1 2 3  ... Next 

Popular tags in SelectScience

Buying guides

Write a Review

Join the Global SelectScience Community Today! It’s FREE!

Helping you make informed decisions about the latest lab products and technologies:

  • Be the first to learn about new technologies
  • 10,000+ trusted product reviews from your peers
  • Compare 500,000 products and manufacturers
  • Get exclusive buying tips from experts
  • Find solutions fast: 10,000+ Application Notes, Webinars and Videos

Connect with 250,000 scientists... All in one place!

Become a member today!